Interview with Dr. Jan Blustein on the effects of pay-for-performance approaches for hospitals. (08:03)Download In October, U.S. acute care hospitals will begin to be “paid for performance” under the Medicare Hospital Value-Based Purchasing program. But accumulating evidence raises doubts about whether the program will in fact improve value. What can be done to redirect the policy?
No takes yet. Share an insight, caveat, or question.
Ryan et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: